Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
26 Epidermides
269 Miscellaneous
2691 Vitamins for external use
D01098 Maxacalcitol (JAN/USAN/INN)
3 Agents affecting metabolism
31 Vitamins
311 Vitamins A and D preparations
3112 Synthetic vitamin D preparations
D01098 Maxacalcitol (JAN/USAN/INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01607 Vitamin D derivatives
DG01606 Activated vitamin D3
D01098 Maxacalcitol
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D01098 Maxacalcitol
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Vitamin D3 like receptor
NR1I1 (VDR)
D01098 Maxacalcitol (JAN/USAN/INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01098
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01098
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01098